March
Deals List

Private equity activity in Europe has held on to its strong start in 2021. According to Mergermarket data, the first three weeks of March yielded no fewer than eight announced European buyouts in excess of £2 billion. Deal-making appetite continues to rise, with a higher level of unsolicited activity by buyers with robust cash reserves and access to credit, although boards and shareholders are increasingly cautious of opportunistic bids that fail to take a longer-term view of company prospects1UK plc up for sale as overseas buyers eye bargains

Source: Financial Times
. There are also rising expectations of more corporate restructuring when COVID-related support from governments and central banks declines.

A consortium of investors has agreed to acquire Aggreko, a UK-based world-leading provider of mobile modular power, temperature control, and energy services2Aggreko PLC was acquired by TDR - I Squared consortium - Mergermarket

Source: MergerMarket
. Demand for Aggreko’s products was severely hit by the pandemic. The deal is expected to reposition Aggreko and accelerate its transition towards net-zero emissions to meet customer demand in clean technology. Aggreko joins a lengthening list of UK-listed companies taken private in 2021, as public-to-privates are fuelled by depressed share prices, the growing success of the vaccine roll-out and the expected recovery.

KPS Capital Partners agreed to acquire the aluminium rolling business from industrials and renewable energy group Norsk Hydro. The division is one of the largest global manufacturers of aluminium rolled products and serves diversified end markets such as construction and beverages. It includes seven plants, one R&D centre, global sales offices, and around 5,000 employees in Germany and Norway3Norsk Hydro ASA (Rolling business) was acquired by KPS Capital Partners, LP - Mergermarket

Source: MergerMarket
. This sale is expected to help Norsk Hydro improve profitability and strengthen its position in low-carbon aluminium, while KPS – a specialist in manufacturing company investments – will carry out improvements at the rolling business that will include an initial focus on safety4Norsk Hydro: Hydro agrees to sell Rolling business area to KPS Capital Partners for EUR 1,380 million

Source: Global Newswire
.

The consortium of investors, along with Cooper management, has agreed to acquire the company in a deal that is valued at £1.7 billion5Cooper Consumer Health SAS was acquired by CVC Capital Partners Limited, Avista Capital Partners LP and Yvan Vindevogel (Private Investor)

Source: MergerMarket
. Cooper Consumer Health is a leading independent over-the-counter drug manufacturer and distributor headquartered in France. The deal stands to strengthen the company’s presence in Europe, while also paving the way for its entrance into US and Chinese markets. Demand for over-the-counter drugs and treatments has risen as a result of the pandemic, and this deal is expected to add to almost £8 billion worth of healthcare acquisitions by private equity firms in Europe in 2021 so far6CVC Capital is Reportedly Near a $2.6B Deal for Pharma Firm Cooper

Source: Bloomberg News
.

CVC Capital Partners Limited has agreed to pay up to £365 million for a 14.3% stake in Six Nations Rugby, sealing a deal that had been delayed for almost two years7Six Nations Rugby Ltd was acquired by CVC Capital Partners Limited

Source: MergerMarket
. The objective of the partnership is to grow the game and attract a wider and more diverse fan base through investments in data and commercial capabilities to develop renowned tournaments. CVC, a former owner of Formula One, has been increasingly active in rugby and has positioned itself to become the dominant commercial player in the sport. Following the postponement of the Six Nations rugby union tournament last year, and corresponding revenue shortfalls, the investment includes contigencies around solvency of the unions and resumption of matches8CVC seals £365m Six Nations rugby deal

Source: Financial Times
.

Blackstone and EQT’s growth capital divisions invested £324.4 million in Epidemic Sound, a global musictech company headquartered in Stockholm that provides royalty-free music to its subscribers, which they can then use in their own content creations. The deal values Epidemic Sound at around £1 billion and will enable it to expand in existing and new markets, while also helping the company to invest more aggressively in its core user experience. Epidemic Sound has grown rapidly as demand in its end-markets for restriction-free music has grown. It previously raised £14.5 million in a £267 million valuation in 2019.

Michael J. Preston
Partner

London
T: +44 20 7614 2255
mpreston@cgsh.com
V-Card

Gabriele Antonazzo
Partner

London
T: +44 20 7614 2353
gantonazzo@cgsh.com
V-Card

Michael James
Partner

London
T: +44 20 7614 2219
mjames@cgsh.com
V-Card